Julie A. Hill

In the record of Julie A. Hill, a single purchase appears, of EUR 6,408, at Cannabist Co Holdings Inc. on March 26, 2024. It weighs little against the 10 sales, which total EUR 2,130,284 with a median of EUR 164,613. The purchase makes up 9% of open-market trades.

All the sales are at Elevance Health, Inc., where Julie A. Hill is a director: EUR 438,286 on July 26, 2019, EUR 421,542 on May 20, 2021 and EUR 297,565 on November 7, 2017 for the three largest.

In all, 22 filings were published from May 23, 2016 to September 26, 2025: 15 at Elevance Health, Inc. and 7 at Cannabist Co Holdings Inc. They include 5 share grants and 6 option exercises. The pace is modest, from 1 to 4 filings a year, with a maximum of 4 in 2017 and 2018. No filing falls in the last twelve months.

Trades by Hill within 30 days of colleagues at Elevance Health, Inc. number 4, 4 and 4. All on the same side. Colleagues in order: Ramiro G. Peru, Robert L. Dixon Jr. and Ronald W. Penczek.